Patient characteristics associated with medication adherence

Clinical Medicine and Research

Volumn 11, Issue 2, 2013, Pages 54-65

  Rolnick, Sharon J ^a,b   Pawloski, Pamala A ^a   Hedblom, Brita D ^a   Asche, Stephen E ^a   Bruzek, Richard J ^b  

^a HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

^b HEALTHPARTNERS INSTITUTE   (United States)

Author keywords

Medication adherence; Patient compliance; Pharmacy benefits

Indexed keywords

ADULT; AGE; AGED; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; EDUCATIONAL STATUS; ELECTRONIC MEDICAL RECORD; ETHNIC DIFFERENCE; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ICD-9-CM; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICATION COMPLIANCE; MULTIPLE SCLEROSIS; OSTEOPOROSIS; PATIENT CODING; RETROSPECTIVE STUDY; SEX DIFFERENCE; SOCIAL STATUS;

MEDICATION ADHERENCE; PATIENT COMPLIANCE; PHARMACY BENEFITS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ASTHMA; COMORBIDITY; CONTINENTAL POPULATION GROUPS; DEPRESSION; DIABETES MELLITUS; EDUCATIONAL STATUS; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; SEX FACTORS; YOUNG ADULT;

EID: 84879386958     PISSN: 15394182     EISSN: 15546179     Source Type: Journal    
DOI: 10.3121/cmr.2013.1113     Document Type: Article

References (39)

1. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004;27:1218-1224.
2. Gold DT, Silverman S. Review of adherence to medications for the treatment of osteoporosis. Curr Osteoporos Rep 2006;4:21-27.
3. Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 2004;19:357-362.
4. LaRosa JH, LaRosa JC. Enhancing drug compliance in lipidlowering treatment. Arch Fam Med 2000;9:1169-1175.
5. Murray MD, Young JM, Morrow DG, Weiner M, Tu W, Hoke SC, Clark DO, Stroupe KT, Wu J, Deer MM, Bruner-England TE, Sowinski KM, Smith FE, Oldridge NB, Gradus-Pizlo I, Murray LL, Brater DC, Weinberger M. Methodology of an ongoing, randomized, controlled trial to improve drug use for elderly patients with chronic heart failure. Am J Geriatr Pharmacother 2004;2:53-65.
6. Osman LM. How do patients' views about medication affect their self-management in asthma? Patient Educ Couns 1997;32:S43-S49.
7. Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med 2004;164:722-732.
8. Chan DC, Shrank WH, Cutler D, Jan S, Fischer MA, Liu J, Avorn J, solomon D, Brookhart MA, Chouldhry NK. Patient, physician, and payment predictors of statin adherence. Med Care 2010;48:196-202.
9. Shin DW, Park JH, Park EC, Kim SY, Kim SG, Choi JY. Antihypertensive medication adherence in cancer survivors and its affecting factors: results of a Korean population-based study. Support Care Cancer 2010;19:211-220.
10. Roebuck MC, Liberman JN, Gemmill-Toyama M, Brennan TA. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff (Millwood) 2011;30:91-99.
11. Yeaw J, Benner JS, Walt JG, Sian S, Smith DB. Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm 2009;15:728-740.
12. Ostrowski M. Report takes aim at America's other drug problem: Poor adherence. [editorial] J Fam Pract 2007;56:734.
13. Oh DL, Sarafian F, Silvestre A, Brown T, Jacobson L, Badri S, Detels R. Evaluation of adherence and factors affecting adherence to combination antiretroviral therapy among White, Hispanic, and Black men in the MACS Cohort. J Acquir Immune Defic Syndr 2009;52:290-293.
14. Poon I, Lal LS, Ford ME, Braun UK. Racial/ethnic disparities in medication use among veterans with hypertension and dementia: a national cohort study. Ann Pharmacother 2009;43:185-193.
15. Steiner JF, Ho PM, Beaty BL, Dickinson LM, Hanratty R, Zeng C, Tavel HM, Havranek EP, Davidson AJ, Magid DJ, Estacio RO. Sociodemographic and clinical characteristics are not clinically useful predictors of refill adherence in patients with hypertension. Circ Cardiovasc Qual Outcomes 2009;2:451-457.
16. Trinacty CM, Adams AS, Soumerai SB, Zhang F, Meigs JB, Piette JD, Ross-Degnan D. Racial differences in long-term adherence to oral antidiabetic drug therapy: a longitudinal cohort study. BMC Health Serv Res 2009;9:24.
17. Yang Y, Thumula V, Pace PF, Banahan BF 3rd, Wilkin NE, Lobb WB. Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study. Clin Ther 2009;31:2178-2188; discussion 2150-2171.
18. Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 2006;40:1280-1288.
19. Halpern R, Agarwal S, Dembek C, Borton L, Lopez-Bresnahan M. Comparison of adherence and persistence among multiple sclerosis patients treated with disease-modifying therapies: a retrospective administrative claims analysis. Patient Prefer Adherence 2011;5:73-84.
20. Briesacher BA, Andrade SE, Fouayzi H, Chan KA. Medication adherence and use of generic drug therapies. Am J Manag Care 2009;15:450-456.
21. Sedjo RL, Cox ER. Lowering copayments: impact of simvastatin patent expiration on patient adherence. Am J Manag Care 2008;14:813-818.
22. Peterson AM, Nau DP, Cramer JA, Benner J, Gwadry-Sridhar F, Nichol M. A checklist for medication compliance and persistence studies using retrospective databases. Value Health 2007;10:3-12.
23. International Society of Pharmacoeconomics and Outcomes Research. ISPOR Medication Compliance Special Interest Group (Med Comp). Draft-Appendix A. Medication compliance special interest group checklist for medication compliance studies using retrospective drug utilization data. Available at: http://www.ispor.org/sigs/eval_checklistdraft. asp. Accessed April 1, 2012.
24. Solomon DH, Iversen MD, Avorn J, Gleeson T, Brookhart MA, Patrick AR, Rekedal L, Shrank WH, Lii J, Losina E, Katz JN. Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trial. Arch Intern Med 2012; 172:477-483.
25. Richards TB, Croner CM, Rushton G, Brown CK, Fowler L. Geographic information systems and public health: mapping the future. Public Health Rep 1999;114:359-373.
26. World Health Organization. Adherence to long-term therapies: evidence for action. Sabaté E, ed. Geneva: World Health Organization; 2003. Available at: http://www.who.int/chp/knowledge/publications/adherence_introduction.pdf. Accessed April 1, 2012.
27. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001;23:1296-1310.
28. Kalichman SC, Ramachandran B, Catz S. Adherence to combination antiretroviral therapies in HIV patients of low health literacy. J Gen Intern Med 1999;14:267-273.
29. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008(2):CD000011.
30. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 2007;297:177-186.
31. Okken VS, Niemeijer MG, Dijkstra A, Baars MW, Said S, Hoogenberg K, ORfgen H, Otten S, Cleophas TJ. The effect of physical, social and psychological factors on drug compliance in patients with mild hypertension. Neth Heart J 2008;16:197-200.
32. Krueger KP, Berger BA, Felkey B. Medication adherence and persistence: a comprehensive review. Adv Ther 2005; 22:313-356.
33. Goff SL, Mazor KM, Meterko V, Dodd K, Sabin J. Patients' beliefs and preferences regarding doctors' medication recommendations. J Gen Intern Med 2008;23:236-241.
34. Lafata JE, Cerghet M, Dobie E, Schultz L, Tunceli K, Reuther J, Elias S. Measuring adherence and persistence to diseasemodifying agents among patients with relapsing remitting multiple sclerosis. J Am Pharm Assoc (2003) 2008; 48:752-757.
35. Kothawala P, Badamgarav E, Ryu S, Miller RM, Halbert RJ. Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis. Mayo Clin Proc 2007;82:1493-1501.
36. Egede LE, Gebregziabher M, Hunt KJ, Axon RN, Echols C, Gilbert GE, Mauldin PD. Regional, geographic, and ethnic differences in medication adherence among adults with type 2 diabetes (February). Ann Pharmacother. 2011 Feb 8. [Epub ahead of print]
37. Chang A, Liberman J, Coulen C, Berger J, Brennan T. Valuebased insurance design and antidiabetic medication adherence. Am J Pharm Benefits 2010;2:39-44.
38. Lau DT, Nau DP. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care 2004;27:2149-2153.
39. Kleinman NL, Schaneman JL, Lynch WD. The association of insulin medication possession ratio, use of insulin glargine, and health benefit costs in employees and spouses with type 2 diabetes. J Occup Environ Med 2008;50:1386-1393.